To establish a platform for the testing of anti-NB activity across a broader range of tumor sites in an immune-competent setting, we developed a transplantation model utilizing primary luciferase-tagged NB cells isolated from tumors arising in Th-MYCN mice [21,26]. The gene discussed is MYCN; the disease is neuroblastoma.